Is the Options Market Predicting a Spike in Integer Holdings Stock?
Investors need to pay close attention to ITGR stock based on the movements in the options market lately.
Stock Taper
Integer Holdings Corporation is a global medical device contract manufacturer offering products across cardiology, neuromodulation, orthopedics, surgical, and battery solutions for OEMs in healthcare, energy, military, and environmental markets.

The Destino™ Twist is a market-ready, deflectable steerable guiding sheath for electrophysiology, structural heart, and peripheral use, part of Integer's Oscor line, offering customizable solutions with regulatory clearance to accelerate medical d...
On October 23, 2025, alongside its Q3 earnings report, Integer Holdings Corporation lowered its full-year 2025 sales guidance and provided a weak forecast for 2026. The company cited the slower-than-anticipated market adoption of key new products, particularly in its electrophysiology (EP) portfolio, as the primary reason for the revision. This news triggered a severe negative reaction from investors, leading to a stock price collapse of over 32% in a single day and prompting multiple securities fraud class-action lawsuits.
In a significant strategic setback, Integer Holdings Corporation was forced to lower its 2025 sales guidance and 2026 growth outlook due to the slower-than-forecasted market adoption of key new electrophysiology (EP) products. This unexpected weakness in a critical growth market triggered a more than 30% drop in the company's stock price and prompted a class-action lawsuit from investors.
Investors need to pay close attention to ITGR stock based on the movements in the options market lately.
Integer (NYSE: ITGR - Get Free Report) and SiBone (NASDAQ: SIBN - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability and institutional ownership. Profitability This table compares Integer and SiBone's net margins, return
PLANO, Texas, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on October 1, 2026, and ending at the close of business on December 31, 2026. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company's common stock or a combination thereof, at the Company's election, in respect of the remainder, if any, of the Company's conversion obligation in excess of the aggregate principal amount of the Notes being converted.
Overall rating: B
| PEER | PRICE | |
|---|---|---|
HAE | $118.28 | COMPARE |
CON | $36.80 | COMPARE |
LIVN | $75.84 | COMPARE |
UFPT | $292.13 | COMPARE |
ADUS | $115.35 | COMPARE |
RXRX | $3.87 | COMPARE |
INSP | $66.63 | COMPARE |
AORT | $21.39 | COMPARE |